Standout Papers

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurr... 2009 2026 2014 2020 1.1k
  1. Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial (2014)
    Éric Pujade-Lauraine, Felix Hilpert et al. Journal of Clinical Oncology
  2. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials (2009)
    Andreas du Bois, Alexander Reuß et al. Cancer

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 71 standout
Sub-graph 1 of 19

Citing Papers

Luminescent Lanthanides in Biorelated Applications: From Molecules to Nanoparticles and Diagnostic Probes to Therapeutics
2025 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
3 intermediate papers

Works of Alexander Reuß being referenced

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Alexander Reuß 3301 490 1322 1556 86 4.2k
Felix Hilpert 2411 470 1568 973 166 3.8k
Jeffrey D. Seidman 3793 589 710 1495 105 5.4k
Matthew Boente 2443 464 1467 760 53 3.7k
Andrea Alberto Lissoni 2882 640 1260 1141 94 4.9k
Ángel J. Lacave 3777 1224 1827 2749 48 5.6k
D. Scott McMeekin 2688 768 1232 1158 119 5.4k
Franco Odicino 3453 572 1245 1561 121 6.6k
Sharon X. Liang 1928 535 1035 635 55 3.1k
Giovanni Aletti 3153 498 779 2212 115 4.7k
Debra A. Bell 1997 409 656 631 80 3.2k

All Works

Loading papers...

Rankless by CCL
2026